Cost-Effectiveness Analysis on 5 Drug Therapeutic Regimens for Children Pneumonia
- VernacularTitle:5种方案治疗小儿肺炎的成本-效果分析
- Author:
Weijun FANG
;
Junfei JIANG
;
Weiqin SHEN
;
Jian CHEN
- Publication Type:Journal Article
- Keywords:
Children pneumonia;
Antibacterials;
Cost-effectiveness analysis
- From:
China Pharmacy
2007;0(35):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the pharmacoeconomic efficacies of 5 drug therapeutic regimens for children pneumonia.METHODS:Using retrospective study and cost-effectiveness analysis to compare the pharmacoeconomic efficacies among the following 5 regimens in treating children pneumonia:amoxicillin sodium/clavulanate potassium(Group A),cefotaxime sodium(Group B),cefoperazone sodium/sulbactam sodium(Group C),cefuroxime sodium(Group D),and azithromycin(Group E).RESULTS:The effective rates of the 5 groups(A,B,C,D and E) were 80.43%,76.09%,65.12%,77.27%,and 91.30%,respectively,and the cost-effectiveness ratios were 1 595.06,1 225.38,1 669.69,1 284.83,and 697.84,respectively.CONCLU-SION:The regimen of azithromycin(group E) is the optimal one among the 5 groups for children pnemonia.
